Lenvatinib as second-line treatment in patients with unresectable hepatocellular carcinoma: A retrospective analysis
ObjectiveThe purpose of this study is to determine the efficacy and safety of lenvatinib as second-line therapy in Chinese patients with unresectable hepatocellular carcinoma (HCC).MethodsWe performed a retrospective analysis of Chinese patients with unresectable HCC who received second-line treatme...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1003426/full |